Cancer News and Research

Latest Cancer News and Research

Online educational materials about breast surgery often difficult to access and understand

Women with breast cancer must often make complex decisions about surgery and treatment options during an already stressful time in their lives, and many of these women may turn to the wide variety of materials available online.

20 Oct 2023

Researchers develop AI-based tool for estimating cancer patient's chances for survival

Researchers have developed an artificial intelligence (AI)–based tool for estimating a newly diagnosed cancer patient's chances for surviving long term, according to a study presented at the American College of Surgeons (ACS) Clinical Congress 2023.

20 Oct 2023

Study reveals how tuberculosis bacteria form cords to resist antibiotics

The ability of Mycobacterium tuberculosis (MTB), a serious respiratory infection, to form snake-like cords was first noted nearly 80 years ago. In a study published October 20 in the journal Cell, investigators report the biophysical mechanisms by which these cords form and demonstrate how several generations of dividing bacteria hang together to create these structures that enable resistance to antibiotics.

20 Oct 2023

New method to study gut microbiome opens door to new medical opportunities

The more diverse species in your gut, the better it is for your health. Now an international team led by the Hudson Institute of Medical Research has found a way to determine which species are important and how they interact to create a healthy microbiome.

20 Oct 2023

California moves ahead of the FDA in banning common candy additives

Halloween candy could be in for a California makeover.

20 Oct 2023

Pioneering partnership supports early-stage innovation against antimicrobial resistance to save lives

Innovate UK, LifeArc, and Medicines Discovery Catapult (MDC) have joined forces to create PACE (Pathways to Antimicrobial Clinical Efficacy), a £30 million initiative supporting early-stage innovation against antimicrobial resistance (AMR) to save lives. PACE has today (19 October 2023) announced its first funding call with up to £10 million available to support innovators developing new antimicrobials.

20 Oct 2023

New funding from Breast Cancer Now supports research on treatment-resistant ER-positive breast cancer

Researchers are investigating how the most common type of breast cancer resists hormone therapy, thanks to new funding from Breast Cancer Now.

20 Oct 2023

Consultant Connect’s technology quickly connects GPs to dermatology specialists

NHS boards across the UK are using a revolutionary technology to give GPs access to rapid advice from consultant dermatologists.

20 Oct 2023

Mediterranean diet intervention may not improve breast cancer prognosis in high-risk patients

Researchers discuss the results of a randomized controlled trial to explore the impact of diet on breast cancer recurrence.

20 Oct 2023

Excessive weight gain during pregnancy linked to higher risk of death decades later

Pregnant people who gained more than the now-recommended amount of weight had a higher risk of death from heart disease or diabetes in the decades that followed, according to new analysis of 50 years of data published in The Lancet and led by researchers from the Perelman School of Medicine at the University of Pennsylvania.

19 Oct 2023

Ferroptosis regulation of GLS2 as a potential therapeutic strategy against liver diseases

A new editorial paper was published in Oncotarget's Volume 14 on October 19, 2023, entitled, "GLS2 shapes ferroptosis in hepatocellular carcinoma."

19 Oct 2023

Biden pick to lead NIH finally has her day, but still gets caught up in drug price debate

A Senate committee finally held a hearing Wednesday on President Joe Biden's pick to lead the National Institutes of Health. But the panel's chair, Sen. Bernie Sanders (I-Vt.), was focused on drug prices — an issue over which the NIH has very little control.

19 Oct 2023

New recommendations released on ethical development and use of AI medical devices

Artificial intelligence (AI)-;of ChatGPT fame-;is increasingly used in medicine to improve diagnosis and treatment of diseases, and to avoid unnecessary screening for patients.

19 Oct 2023

Potato starch supplement may help prevent gvhd in bone marrow transplant patients

Researchers at Baylor College of Medicine and the University of Michigan conducted a phase I pilot study to assess the feasibility of using potato starch as a dietary intervention to modify the gut microbiome in bone marrow transplant patients.

19 Oct 2023

New method uses extracellular vesicles to enhance immunotherapy responses in glioblastoma

A team of researchers at The University of Texas MD Anderson Cancer Center has developed a new method for using extracellular vesicles to enhance responses to immunotherapy in glioblastoma, potentially opening the door for wider use of engineered messenger RNA (mRNA) for cancer therapy.

19 Oct 2023

Collaborative team receives NCI grant to study how to improve immunotherapy for diffuse midline gliomas

Each year, approximately 200 to 300 children in the United States are diagnosed with diffuse midline gliomas (DMG), a tumor that begins in the brain or spinal cord.

19 Oct 2023

MuTaLig: A multi-target paradigm for innovative drug discoveries

Everyone at some point in their life may need to take medication to treat an illness or disease. By finding new and better ways to create drugs, the COST Action Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig) helped improve the effectiveness and safety of the medications, which can ultimately benefit people's health and well-being.

19 Oct 2023

Cervical cancer rates increasing in Appalachian Kentucky

While the overall incidence and death rates from cervical cancer have dropped in the U.S., the opposite has been occurring in Appalachian Kentucky – a steady increase. The death rate from cervical cancer in Appalachian Kentucky is now twice that of the national rate.

19 Oct 2023

Lactate-producing intratumoral bacteria drive resistance to radiation therapy

Researchers at The University of Texas MD Anderson Cancer Center have discovered that lactate-producing intratumoral bacteria drives resistance to radiation therapy, suggesting that lactic acid-producing bacteria present in various cancers may serve as novel therapeutic targets.

19 Oct 2023

"Two-for-one" cancer immunotherapy more effective and at least as safe as standard treatments

A "two-for-one" cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scientists from UPMC Hillman Cancer Center who led an international, early-phase clinical trial report today in the journal Nature Medicine.

19 Oct 2023

Cancer News and Research

Latest Cancer News and Research

Online educational materials about breast surgery often difficult to access and understand

Researchers develop AI-based tool for estimating cancer patient's chances for survival

Study reveals how tuberculosis bacteria form cords to resist antibiotics

New method to study gut microbiome opens door to new medical opportunities

California moves ahead of the FDA in banning common candy additives

Pioneering partnership supports early-stage innovation against antimicrobial resistance to save lives

New funding from Breast Cancer Now supports research on treatment-resistant ER-positive breast cancer

Consultant Connect’s technology quickly connects GPs to dermatology specialists

Mediterranean diet intervention may not improve breast cancer prognosis in high-risk patients

Excessive weight gain during pregnancy linked to higher risk of death decades later

Ferroptosis regulation of GLS2 as a potential therapeutic strategy against liver diseases

Biden pick to lead NIH finally has her day, but still gets caught up in drug price debate

New recommendations released on ethical development and use of AI medical devices

Potato starch supplement may help prevent gvhd in bone marrow transplant patients

New method uses extracellular vesicles to enhance immunotherapy responses in glioblastoma

Collaborative team receives NCI grant to study how to improve immunotherapy for diffuse midline gliomas

MuTaLig: A multi-target paradigm for innovative drug discoveries

Cervical cancer rates increasing in Appalachian Kentucky

Lactate-producing intratumoral bacteria drive resistance to radiation therapy

"Two-for-one" cancer immunotherapy more effective and at least as safe as standard treatments

Understanding the DNA Damage Response in Innate Immunity eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in